JOSÉ MANUEL BAEYENS CABRERA-rekin lankidetzan egindako argitalpenak (10)

2022

  1. Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer

    BioImpacts, Vol. 12, Núm. 6, pp. 515-531

2021

  1. Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes

    Biomedicine and Pharmacotherapy, Vol. 133

2020

  1. Intracolonic Mustard Oil Induces Visceral Pain in Mice by TRPA1-Dependent and -Independent Mechanisms: Role of Tissue Injury and P2X Receptors

    Frontiers in Pharmacology, Vol. 11

  2. Sigma-1 receptors control neuropathic pain and macrophage infiltration into the dorsal root ganglion after peripheral nerve injury

    FASEB Journal, Vol. 34, Núm. 4, pp. 5951-5966

2019

  1. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer

    Pharmacological Research, Vol. 141, pp. 451-465

  2. Sigma-1 receptor inhibition reduces neuropathic pain induced by partial sciatic nerve transection in mice by opioid-dependent and -independent mechanisms

    Frontiers in Pharmacology, Vol. 10, Núm. JUN

2018

  1. Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors

    Neuropharmacology, Vol. 135, pp. 328-342

2017

  1. Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines

    Nano Research, Vol. 10, Núm. 3, pp. 856-875

  2. Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro

    Scientific Reports, Vol. 7, Núm. 1

2014

  1. Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: Role of peripheral sigma-1 receptors

    Psychopharmacology, Vol. 231, Núm. 19, pp. 3855-3869